| NCT Number | NCT05346510 |
| Lead Sponsor | Shengjing Hospital |
| Conditions | Breast Cancer |
| Enrollment | 500 participants |
| Start Date | 2022-03-01 |
| Primary Completion | 2022-09-01 (estimated) |
| Study Completion | 2027-08-31 (estimated) |
| Updated on ClinicalTrials.gov | 2022-04-26 |